MARSH & MCLENNAN COMPANIES, INC. (MMC) Form 10-Q — Oct 15, 2026
Marsh & McLennan reported Q3 2026 revenue of $6.9 billion, up 8% (5% underlying), with diluted EPS of $1.69, up 12% year over year. Consulting led growth at +9% (8% underlying) while Reinsurance declined 6%. Nine-month results were dented by a $569 million net charge related to the Greensill litigation settlements, which concluded Marsh's involvement in the Australian proceedings; consolidated YTD operating income fell 3% to $4.9 billion and YTD diluted EPS slipped 1% to $6.68. The company accelerated its Thrive restructuring program, raising the cost estimate from $500 million to $750 million while lifting expected annualized savings to $600 million.
Key figures
- Eps
- 1.69
- Revenue
- 6863
- Net Income
- 808
- Revenue Yoy
- 8% (Q3 2026); 5% underlying
- Total Assets
- 59806
- Cash Position
- 1842
- Shares Outstanding
- 475514327
- Nine month revenue
- 21864
- Greensill charge q3
- 144
- Q3 2025 diluted eps
- 1.51
- Q3 2026 diluted eps
- 1.69
- Effective tax rate q3
- 21.3%
- Nine month diluted eps
- 6.68
- Buybacks nine months usd
- 2.0 billion
- Deasterra remeasurement gain
- 126
- Greensill charge nine months
- 569
- Quarterly dividend per share
- 0.99
- Thrive program cost estimate
- 750
- Shares repurchased nine months
- 11.4 million
- Remaining buyback authorization
- approximately $3.7 billion
- Thrive expected annualized savings
- 600
- Acquisitions 2026 purchase consideration
- 550
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.